EntreMed(美国)

EntreMed

EntreMed www.entremed.comEntreMed,Inc.是一家致力于开发ENMD-2076的临床阶段制药公司。ENMD-2076是用于治疗癌症的选择性血管生成激酶抑制剂。ENMD-2076目前正在进行一项多中心二期卵巢癌研究，并且已经完成了多个有关实体肿瘤、多发性骨髓瘤和白血病的一期研究EntreMed,Inc.9640MedicalCenterDriveRockville, MD20850Phone:(240)864-2600Fax:(301)315-2437英创远达(北京)生物医药科技有限公司EntreMed(Beijing),Inc.HanhaiCulturePlazaSuite716Building28-1XiangJunBeiLiChaoyangDistrictBeijing100025P.R.ChinaInvestorRelations(240)864-2643investorrelations@entremed.comEntreMed,Inc.isaclinical-stagepharmaceuticalcompanyemployingadrugdevelopmentstrategyprimarilyintheUnitedStatesandChinatodeveloptargetedtherapeuticsfortheglobalmarket.Itsleadcompound,ENMD-2076,aselectiveangiogenickinaseinhibitor,hascompletedseveralPhase1studiesinsolidtumors,multiplemyeloma,andleukemia,